Filing Details

Accession Number:
0001349929-15-000058
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-16 08:26:00
Reporting Period:
2015-11-12
Filing Date:
2015-11-16
Accepted Time:
2015-11-16 08:26:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1349929 Cancer Genetics Inc CGIX Services-Medical Laboratories (8071) 043462475
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
897464 John Pappajohn 201 Route 17 North
2Nd Floor
Rutherford NJ 07070
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Acquisiton 2015-11-12 100,000 $0.00 1,621,789 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.0001 Per Share Warrant (right to buy) Acquisiton 2015-11-12 100,000 $0.00 100,000 $5.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
100,000 2015-11-12 2020-11-12 No 4 P Direct
Footnotes
  1. The reported securities were purchased in an underwritten public offering which closed on November 12, 2015. The reported securities were issued pursuant to a prospectus supplement in connection with a takedown from the Company's shelf registration statement on Form S-3 (File No. 333-196374), filed with the SEC and effective on June 5, 2014.
  2. The reported securities consist of one share of common stock, par value $0.0001 per share (the "Common Stock") and an accompanying warrant to purchase one share of Common Stock for $4.00 per share and warrant.